pentobarbital will decrease the level or result of theophylline by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep an eye on.

pentobarbital will lower the level or effect of fosaprepitant by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.

pentobarbital will lessen the extent or outcome of tofacitinib by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. Lack of, or lowered response to tofacitinib may well happen when coadministered with potent CYP3A4 inducers

pentobarbital will lower the extent or effect of fesoterodine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Observe.

Barbiturates may cause fetal problems when administered into a pregnant girl; retrospective, case-managed scientific studies have prompt a connection involving maternal consumption of barbiturates and an increased-than-expected incidence of fetal abnormalities

fentanyl transmucosal and pentobarbital each increase sedation. Prevent or Use Alternate Drug. Limit use to clients for whom substitute procedure options are inadequate

Parenteral answers of barbiturates are very alkaline; Intense care needs to be taken in order to avoid perivascular extravasation or intra-arterial injection; extravascular injection may possibly bring about community tissue hurt with subsequent necrosis; outcomes of intra-arterial injection may perhaps differ from transient pain to gangrene from the limb; any complaint of ache while in the limb warrants halting the injection

pentobarbital will reduce the extent or result of dapsone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Significance Mysterious.

pentobarbital will decrease the level or influence of montelukast by read more influencing hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Significance Mysterious.

Contraindicated (one)pentobarbital will decrease the extent or influence of lorlatinib by impacting hepatic/intestinal enzyme CYP3A4 metabolism.

Monitor Carefully (1)pentobarbital will decrease the level or impact of glecaprevir/pibrentasvir by influencing hepatic/intestinal enzyme CYP3A4 metabolism.

pentobarbital will lower the extent or impact of prednisone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep track of.

pentobarbital will decrease the level or result of avanafil by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Check. For individuals with ED, keep track of response diligently because of prospective for diminished success.

pentobarbital will minimize the level or result of itraconazole by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Importance Unknown.